Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-07

FDA Approved: MELOXICAM — Original Application (XLCare Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved the original application for MELOXICAM (meloxicam), a generic version manufactured by XLCare Pharmaceuticals, Inc., under ANDA217579.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MELOXICAM (MELOXICAM)

Snippet

ORIG AP for MELOXICAM (MELOXICAM)